Product Images Rivastigmine Transdermal System

This is not useful. It seems to be a mix of random characters and words, possibly from different documents.*

The text provides instructions for safely discarding the Rivastigmine Transdermal Patch after every 24 hours of use. The used patch should be folded in half with the sticky side inwards and placed in its original pouch before being discarded safely out of the reach of children. Washing hands with soap and water is also recommended. For further inquiries, contact Alvogen at the provided phone number.*

This appears to be a chart showing the blood level of Rivastigmine measured in ng/mL at different dosages (24 hour increments) and for different group sizes (n) of 19 or 22. Not available for what purpose this data was collected.*

The text appears to be a graph showing the clinical improvement and decline over weeks of treatment with Rivastigmine Patch 13.3 mg24hr compared to 05 my2etr. There is not enough text to provide further details or context.*

The text appears to be a product label for a Pouch Rivastigmine Patch with a protective liner. The patch contains the medicine RIVASTIGMINE and is a transdermal system. It includes an adhesive with a medicine called Qavogen® and has an outside backing with a cover sheet.*

This appears to be a list of body parts with checkboxes or tick marks to indicate left or right side of the body. Specifically, it includes options for the upper arm, side of the chest, upper back, and lower back. It may be a form or questionnaire used in a medical or diagnostic setting.*

This appears to be a set of instructions for a product that involves a patch. The instructions suggest folding the patch and placing it in the trash, and then folding the sticky sides together to create an empty pouch. It also warns to keep the product away from children and pets. However, the text is incomplete and does not provide enough context to determine the specific product or its purpose. The final characters "T 5 5" do not appear to be relevant to the instructions.*

This is a medication package containing a Rivastigmine Transdermal System, delivering 13.3 mg of medication over 24 hours through a patch that should not be cut. It is for transdermal use only and must be applied to intact skin immediately after opening. The package insert should be consulted for complete application instructions. The pouch should be retained for discarding the patch after use. The medication should be stored at a temperature of 15°C to 30°C (59°F to 86°F) and kept out of reach of children. The package was made in Germany and distributed by Alvogen, Inc. in Morristown, NJ. The instructions include an expiration date, which is not included in the text.*

This is a description of a medication called Rivastigmine Transdermal System, which is intended for transdermal use only. The package contains one system that delivers 4.6mg/24 hours, and it should only be applied to intact skin using the instructions provided on the package insert. It is important not to cut the patch, and it should be replaced with a new patch every 24 hours. The patch should be stored at a temperature between 25°C to 30°C, and kept out of reach of children. The medication is distributed by Alvogen, Inc., made in Germany, and the package includes a pouch that should be used for discarding the patch after use. Lot number 304-11-01 was last revised in December 2020.*

This is a description for a medication with the NDC code 47781-305-11. The medication is Rivastigmine, which comes as a transdermal patch. The package contains three systems, each delivering 9.5 mg per 24 hours, and should only be used for transdermal application. Each pack contains only one system with no cutting allowed. The package insert provides complete application instructions. The patch should be replaced every 24 hours and applied to intact skin immediately after removal from the pouch. The patch should not be worn together with another. The medication is distributed by Alvogen, Inc from Moristown, New Jersey in the United States, and was made in Germany. It should be stored at 25°C (77°F), but excursions are allowed between 10°C to 15°C (59°F to 86°F). The pouch should be retained for discarding the patch after use, and the medication should be kept out of reach of children.*

This text appears to be describing the layers of a product, including a coversheet, backing film, reservoir layer, adhesive layer, and release liner. It is likely related to some sort of adhesive or protective film.*